Follow
Robert Ihry
Robert Ihry
Novartis Institutes of Biomedical Research
Verified email at novartis.com
Title
Cited by
Cited by
Year
p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells
RJ Ihry, KA Worringer, MR Salick, E Frias, D Ho, K Theriault, S Kommineni, ...
Nature Medicine, 2018
9942018
Genetic ablation of AXL does not protect human neural progenitor cells and cerebral organoids from Zika virus infection
MF Wells, MR Salick, O Wiskow, DJ Ho, KA Worringer, RJ Ihry, ...
Cell stem cell 19 (6), 703-708, 2016
2892016
DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discovery
JJAK Chaoyang Ye, Daniel J. Ho, Marilisa Neri, Chian Yang, Tripti Kulkarni ...
Nature Communications, 2018
1632018
Genome-Scale CRISPR Screens Identify Human Pluripotency-Specific Genes
Cell Reports 27 (2), 616-630, 2019
732019
Translational Control by the DEAD Box RNA Helicase belle Regulates Ecdysone-Triggered Transcriptional Cascades
RJ Ihry, AL Sapiro, A Bashirullah
PLoS genetics 8 (11), e1003085, 2012
472012
INO80-dependent regression of ecdysone-induced transcriptional responses regulates developmental timing in Drosophila
SD Neuman, RJ Ihry, KM Gruetzmacher, A Bashirullah
Developmental biology 387 (2), 229-239, 2014
222014
Genetic Control of Specificity to Steroid-Triggered Responses in Drosophila
RJ Ihry, A Bashirullah
Genetics 196 (3), 767-780, 2014
222014
DRUG-seq provides unbiased biological activity readouts for neuroscience drug discovery
J Li, DJ Ho, M Henault, C Yang, M Neri, R Ge, S Renner, L Mansur, ...
ACS Chemical Biology 17 (6), 1401-1414, 2022
152022
Genomic regions influencing gene expression of the HMW glutenins in wheat
EW Storlie, RJ Ihry, LM Baehr, KA Tieszen, JH Engbers, ...
Theoretical and Applied Genetics 118, 295-303, 2009
152009
Rapid Recombination Mapping for High-Throughput Genetic Screens in Drosophila
AL Sapiro, RJ Ihry, DL Buhr, KM Konieczko, SM Ives, AK Engstrom, ...
G3: Genes, Genomes, Genetics 3 (12), 2313-2319, 2013
102013
P53 toxicity is a hurdle to CRISPR
RJ Ihry, KA Worringer, MR Salick, E Frias, D Ho, K Theriault, S Kommineni, ...
CAS9 screening and engineering in human pluripotent stem cells. bioRxiv 168443, 2017
42017
DRUG-seq provides unbiased biological activity readouts for drug discovery
J Li, DJ Ho, M Henault, C Yang, M Neri, R Ge, S Renner, L Mansur, ...
Biorxiv, 2021.06. 07.447456, 2021
22021
Genome-Scale CRISPR Screening Identifies Novel Human Pluripotent Gene Networks
bioRxiv, 2018
22018
Regulators of human pluripotent stem cells and uses thereof
R Ihry, A Kaykas, M Hild
WO Patent WO2019213276A9, 2018
22018
Patient Brain Organoids Identify a Link between the 16p11.2 Copy Number Variant and the RBFOX1 Gene.
IRJ Kostic M, Raymond JJ, Freyre CAC, Henry B, Tumkaya T, Khlghatyan J ...
ACS Chem Neurosci. 15 (14(22)), 3993-4012, 2023
1*2023
Methods and compositions for enhancing gene editing
I Robert, A Kaykas, K Worringer
US Patent App. 15/800,352, 2018
12018
Enhancing the Small-Scale Screenable Biological Space beyond Known Chemogenomics Libraries with Gray Chemical Matter─ Compounds with Novel Mechanisms from High-Throughput …
JR Thomas, C Shelton IV, J Murphy, S Brittain, MA Bray, P Aspesi, ...
ACS Chemical Biology, 2024
2024
New insights from old data-Hunting for compounds with novel mechanisms using cellular high-throughput screening profiles with Grey Chemical Matter
S Renner, J Thomas, C Shelton, S Brittain, MA Bray, P Aspesi Jr, ...
2023
New insights from old data-Hunting for compounds with novel mechanisms using cellular high-throughput screening profiles with Grey Chemical Matter
JR Thomas, C Shelton IV, J Murphy, S Brittain, MA Bray, P Aspesi, ...
2023
TRAWLING: a Transcriptome Reference Aware of spLIciNG events
ND Nanni, A Reyes, D Ho, R Ihry, A Kauffmann, EY Durand, A de Weck
biorxiv, 2021.12. 03.471115, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20